Atlas Trials

A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes

Clinical trial NCT02814838 · COMPLETED

Trial details

NCT number
NCT02814838
Sponsor
Dompé Farmaceutici S.p.A
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus, Insulin-Dependent
Start date
2016-08-01
Primary completion
2019-05-15
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.